ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 117 filers reported holding ADAMAS PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 0.28 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $107,000 | -29.1% | 20,995 | -0.7% | 0.00% | – |
| Q1 2019 | $151,000 | -6.2% | 21,149 | +12.5% | 0.00% | – |
| Q4 2018 | $161,000 | -52.2% | 18,796 | +11.9% | 0.00% | – |
| Q3 2018 | $337,000 | -63.2% | 16,795 | -52.7% | 0.00% | -100.0% |
| Q2 2018 | $917,000 | +43.3% | 35,507 | +32.8% | 0.00% | 0.0% |
| Q1 2018 | $640,000 | -25.5% | 26,743 | +5.6% | 0.00% | 0.0% |
| Q4 2017 | $859,000 | +23.2% | 25,335 | -22.9% | 0.00% | 0.0% |
| Q3 2017 | $697,000 | +152.5% | 32,878 | +95.5% | 0.00% | – |
| Q3 2016 | $276,000 | -48.1% | 16,817 | -52.1% | 0.00% | -100.0% |
| Q2 2016 | $532,000 | -15.8% | 35,116 | -19.6% | 0.00% | 0.0% |
| Q1 2016 | $632,000 | +191.2% | 43,682 | +470.0% | 0.00% | – |
| Q4 2015 | $217,000 | -23.3% | 7,664 | -54.7% | 0.00% | – |
| Q3 2015 | $283,000 | -40.2% | 16,914 | -6.3% | 0.00% | – |
| Q2 2015 | $473,000 | – | 18,053 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 751,012 | $3,841,000 | 3.73% |
| Healthcare Value Capital, LLC | 200,000 | $1,023,000 | 1.85% |
| DELTEC ASSET MANAGEMENT LLC | 574,886 | $2,941,000 | 0.74% |
| Kerrisdale Advisers, LLC | 229,347 | $1,173,000 | 0.74% |
| Mosaic Family Wealth, LLC | 91,314 | $609,000 | 0.25% |
| Worth Venture Partners, LLC | 77,384 | $396,000 | 0.23% |
| ARMISTICE CAPITAL, LLC | 536,000 | $2,742,000 | 0.18% |
| EMERALD ADVISERS, LLC | 639,094 | $3,269,000 | 0.15% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 609,019 | $3,115,000 | 0.14% |
| DUDLEY & SHANLEY, INC. | 67,400 | $345,000 | 0.08% |